My Quote Request
6505-01-165-1482
20 Products
ZANTAC TABLETS
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011651482
NSN
6505-01-165-1482
ZANTAC TABLETS
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011651482
NSN
6505-01-165-1482
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
NDC50111-0391-02
SALSALATE TABLETS,USP
NSN, MFG P/N
6505011646861
NSN
6505-01-164-6861
NDC50111-0391-02
SALSALATE TABLETS,USP
NSN, MFG P/N
6505011646861
NSN
6505-01-164-6861
MFG
SIDMAK LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS SALSALATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALSALATE TABLETS 750MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00067-0300-68
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
NDC00067-0300-68
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00075-0300-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
NDC00075-0300-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00258-3625-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
NDC00258-3625-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
MFG
INWOOD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00603-5952-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
NDC00603-5952-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00904-7849-60
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
NDC00904-7849-60
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
SLO-BID
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
SLO-BID
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
SLO-BID GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
SLO-BID GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648736
NSN
6505-01-164-8736
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
Related Searches:
NDC00075-0300-62
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
NDC00075-0300-62
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
NDC00258-3625-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
NDC00258-3625-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
MFG
INWOOD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
NDC00603-5952-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
NDC00603-5952-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
NDC00904-7849-60
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
NDC00904-7849-60
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
SLO-BID 300
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
SLO-BID 300
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
SLO-BID 300 GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
SLO-BID 300 GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011648737
NSN
6505-01-164-8737
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID GYROCAP BY RORER PHARM
Related Searches:
2B0852
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505011648859
NSN
6505-01-164-8859
2B0852
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505011648859
NSN
6505-01-164-8859
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 80 MG GENTAMICIN PER ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP EQUIP TO 80MG 50ML 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PLASTIC BAG CONTAINS HEAVY GAUGE PLASTIC HANGER STRAP AND IS SUPPLIED IN AN OVERPOUCH
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
GENTAMICIN VIAFLEX
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505011648859
NSN
6505-01-164-8859
GENTAMICIN VIAFLEX
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505011648859
NSN
6505-01-164-8859
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 80 MG GENTAMICIN PER ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP EQUIP TO 80MG 50ML 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PLASTIC BAG CONTAINS HEAVY GAUGE PLASTIC HANGER STRAP AND IS SUPPLIED IN AN OVERPOUCH
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00264-5816-38
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505011648859
NSN
6505-01-164-8859
NDC00264-5816-38
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505011648859
NSN
6505-01-164-8859
MFG
B BRAUN MEDICAL INC WOUND CARE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 80 MG GENTAMICIN PER ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP EQUIP TO 80MG 50ML 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PLASTIC BAG CONTAINS HEAVY GAUGE PLASTIC HANGER STRAP AND IS SUPPLIED IN AN OVERPOUCH
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00173-0344-47
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011651482
NSN
6505-01-165-1482
NDC00173-0344-47
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011651482
NSN
6505-01-165-1482
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
ZANTAC
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011651482
NSN
6505-01-165-1482
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS

